VIZIENT, INC. for VIZIENT INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Not-for-profit hospital tax-exemption - Conducted outreach in support of ongoing efforts by hospitals to provide community benefit and sought clear and consistent guidance for maintaining tax-exemption.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW New | — |
| CIDETTE PERRIN | — |
| STEVEN RIXEN New | — |
Health Issues HCR
Hospital Group Purchasing Organizations - Provided ongoing outreach and education efforts regarding the value delivered by group purchasing organizations for hospitals across the country. Drug Prices - Tracked ongoing discussion and offered information relating to how hospital group purchasing organizations help hold down cost growth of prescription drugs. Monitored legislative proposals related to increasing prices in prescription drugs. 340B Drug Discount Program - Monitored proposals to modify the 340B Drug Discount program. 21st Century Cures (H.R. 6) - Tracked the development of Senate counterpart to the House-passed 21st Century Cures legislation and raised concerns about potential offsets that could impact hospital payments. Opioid legislation (S. 524, the Comprehensive Addiction and Recovery Act, House package including multiple bills) - Supported passage of legislation to address growing challenges related to opioid abuse and addiction. Zika Virus - Monitored ongoing debate around legislative packages to provide funding to combat the spread of the Zika Virus.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW New | — |
| CIDETTE PERRIN | — |
| STEVEN RIXEN New | — |
Medicare/Medicaid MMM
Hospital outpatient department reimbursement (H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage of legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement to be grandfathered in under previous outpatient reimbursement rules, make modifications to the Medicare hospital readmissions reduction program, and other changes. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement for services delivered in a hospital setting. Medicare Total Quality Hospital Star Ratings - Advocated for a delay in the release of the new star ratings until the changes were made to the proposed methodology. Medicare Part B Drug Demonstration - Monitored the proposed demonstration and the impact it may have on hospitals. Tracked Congressional activity reviewing the proposal and legislation (H.R. 5122) to prevent CMS from moving forward with the demonstration.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHOSHANA KRILOW New | — |
| CIDETTE PERRIN | — |
| STEVEN RIXEN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.